FDA official logo
GSRS logo
PFDA official logo

BROLUCIZUMAB

  • UNII: XSZ53G39H5
  • Preferred Substance Name: BROLUCIZUMAB

  • 1531589-13-5
  • BEOVU
  • BROLUCIZUMAB [INN]
  • BROLUCIZUMAB [JAN]
  • BROLUCIZUMAB [MI]
  • BROLUCIZUMAB [USAN]
  • BROLUCIZUMAB [WHO-DD]
  • BROLUCIZUMAB DBLL [WHO-DD]
  • BROLUCIZUMAB-DBLL
  • ESBA1008
  • ESBA-1008
  • IMMUNOGLOBULIN, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL ESBA1008 SCFV FRAGMENT)
  • RTH258
  • RTH-258

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.